Ginkgo Bioworks Holdings Statistics

Total Valuation

BMV:DNA has a market cap or net worth of MXN 9.57 billion. The enterprise value is 8.86 billion.

Market Cap	9.57B
Enterprise Value	8.86B

Important Dates

The next estimated earnings date is Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	43.82M
Shares Outstanding	n/a
Shares Change (YoY)	+7.58%
Shares Change (QoQ)	+1.41%
Owned by Insiders (%)	16.96%
Owned by Institutions (%)	54.15%
Float	40.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.89
PB Ratio	0.93
P/TBV Ratio	1.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.42
EV / Sales	2.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.58

Financial Position

The company has a current ratio of 4.39, with a Debt / Equity ratio of 0.76.

Current Ratio	4.39
Quick Ratio	4.20
Debt / Equity	0.76
Debt / EBITDA	n/a
Debt / FCF	-2.26
Interest Coverage	-3,534.07

Financial Efficiency

Return on equity (ROE) is -50.02% and return on invested capital (ROIC) is -18.65%.

Return on Equity (ROE)	-50.02%
Return on Assets (ROA)	-15.55%
Return on Invested Capital (ROIC)	-18.65%
Return on Capital Employed (ROCE)	-30.93%
Revenue Per Employee	3.97M
Profits Per Employee	-7.47M
Employee Count	834
Asset Turnover	0.14
Inventory Turnover	n/a

Taxes

Income Tax	-9.52M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +279.02% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+279.02%
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	32.65
Average Volume (20 Days)	314

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.90

Income Statement

In the last 12 months, BMV:DNA had revenue of MXN 3.31 billion and -6.23 billion in losses. Loss per share was -113.96.

Revenue	3.31B
Gross Profit	2.41B
Operating Income	-6.09B
Pretax Income	-6.24B
Net Income	-6.23B
EBITDA	-4.99B
EBIT	-6.09B
Loss Per Share	-113.96

Full Income Statement

Balance Sheet

The company has 8.47 billion in cash and 7.76 billion in debt, giving a net cash position of 715.20 million.

Cash & Cash Equivalents	8.47B
Total Debt	7.76B
Net Cash	715.20M
Net Cash Per Share	n/a
Equity (Book Value)	10.27B
Book Value Per Share	180.65
Working Capital	7.17B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.04 billion and capital expenditures -391.97 million, giving a free cash flow of -3.43 billion.

Operating Cash Flow	-3.04B
Capital Expenditures	-391.97M
Free Cash Flow	-3.43B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 72.71%, with operating and profit margins of -183.94% and -188.00%.

Gross Margin	72.71%
Operating Margin	-183.94%
Pretax Margin	-188.29%
Profit Margin	-188.00%
EBITDA Margin	-150.56%
EBIT Margin	-183.94%
FCF Margin	n/a

Dividends & Yields

BMV:DNA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.58%
Shareholder Yield	-7.58%
Earnings Yield	-65.11%
FCF Yield	-35.89%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 20, 2024. It was a reverse split with a ratio of 0.025.

Last Split Date	Aug 20, 2024
Split Type	Reverse
Split Ratio	0.025

Scores

BMV:DNA has an Altman Z-Score of -7.01 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.01
Piotroski F-Score	2